Antinuclear Antibody (ANA) Test Market Size, Opportunities, Company Profile, Developments and Outlook 2029
Antinuclear Antibody (ANA) Test Market is experiencing significant growth, driven by the rising prevalence of autoimmune disorders and advancements in diagnostic technologies. The market was valued at USD 2.3 billion in 2021 and is projected to grow at a CAGR of 12.4% during the forecast period of 2022 to 2029. 🔬 Market Overview Tests for antinuclear antibodies identify autoantibodies that...
0 Commentarii 0 Distribuiri 678 Views 0 previzualizare